Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: Results of a phase 1/2 study

Philip J. Mease, Nathan Wei, Edward J. Fudman, Alan J. Kivitz, Joy Schechtman, Robert G. Trapp, Kathryn F. Hobbs, Maria Greenwald, Antony Hou, Stephen A. Bookbinder, Galen E. Graham, Craig W. Wiesenhutter, Larry Willis, Eric M. Ruderman, Joseph Z. Forstot, Michael J. Maricic, Kathryn H. Dao, Charles H. Pritchard, Darrell N. Fiske, Francis X. BurchH. Malin Prupas, Pervin Anklesaria, Alison E. Heald

Research output: Contribution to journalArticle

77 Scopus citations

Fingerprint Dive into the research topics of 'Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: Results of a phase 1/2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences